Treatment with digitoxin plus MEK inhibitor significantly reduced ROS levels in melanomas from all three patients relative to control tumours or tumours treated only with digitoxin or MEK inhibitor (in 2 of 3 melanomas) (Fig. 6d). The gene discussed is MAP2K7; the disease is melanoma.